Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹24.17
0.15 (0.62%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹133 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
93.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹15.2+59.0%
52W High₹52.5-54.0%
Current Price
₹24.17
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹22.96
Upper Circuit₹25.38
Reference Price
₹24.17
Investment Checklist
Symmetrical Triangle on 1W — target ₹22.96
Descending Channel on 1D — target ₹23.44
Composite score -36.49 (SELL) with 49.0% confidence
10/20 Bullish Cross detected 4 day(s) ago
EMA(50) Crossover: Price crossed above EMA(50): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
49%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
EMA20
23.92
EMA50
24.16
EMA200
30.1
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹24.20
₹24.95
₹25.91
₹27.50
₹28.63
Support (Below)
₹23.86
₹23.40
₹23.01
₹22.50
₹20.90
Volume Analysis
TrendSTABLE
Change+3.90%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bullish Cross
4 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹23.93
3% Risk₹23.44
5% Risk₹22.96
7% Risk (Custom)
₹22.48Technical Levels
1x ATR (Volatility)₹23.09
2x ATR (Swing)₹22.01
3x ATR (Trend)₹20.93
Immediate Support₹23.86
Moving Averages
EMA 9 (Short-term)₹23.91
EMA 20 (Medium-term)₹23.92
EMA 50 (Trend)₹24.16
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹76.3 Cr | ₹70.7 Cr | ₹56.2 Cr | ₹72.5 Cr |
| Net Profit | ₹8.6 Cr | ₹29,01,000 | ₹20,90,000 | ₹30,50,000 |
| EPS | — | ₹0.05 | ₹0.04 | ₹0.06 |
| Operating Profit | ₹10.9 Cr | ₹2.4 Cr | ₹2.8 Cr | ₹3.2 Cr |
ROE
10.82%
ROCE
11.08%
Debt/Equity
0.23
Current Ratio
4.45
OPM
4.39%
NPM
0.42%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| BALAXI PHARMACEUTICALS LIMITED | ₹24.17 | +0.62% | 93.6 | ₹133 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 30 May 2024 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share | STOCK_SPLIT |
| 01 Jul 2022 | Annual General Meeting/Dividend - Rs 0.50 Per Share | AGM |
| 21 Sept 2017 | Annual General Meeting | AGM |
| 22 Sept 2016 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
| Date | Purpose | Links |
|---|---|---|
| 28 May 2026 | Financial Results/Other business matters | |
| 28 May 2026 | Board Meeting Intimation | |
| 28 Jan 2026 | Board Meeting Intimation | |
| 28 Jan 2026 | Financial Results/Other business matters | |
| 11 Nov 2025 | Financial Results/Other business matters |
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
No news available at the moment.